Dre Haley Abivardi, DMD
CEO & Co-Founder
Dr. Haley Abivardi is Chief Executive Officer and Co-Founder of vVARDIS, a Swiss high-growth healthcare company pioneering biomimetic, non-invasive dental technologies for caries management. Since co-founding vVARDIS in 2020 with her sister, Dr. Goly Abivardi, Haley has driven the company’s growth with an entrepreneurial vision, advancing vVARDIS’ mission to expand access to innovative dental care solutions and address tooth decay, the world’s most prevalent non-communicable disease and the number one chronic disease among children.
Haley earned her Doctor of Dental Medicine (DMD) from the University of Zurich, where she also completed her dissertation in 1998. She began her career co-leading a public pediatric dental clinic in Switzerland, providing dental care to thousands of children, particularly from underserved communities. In 2003, she and her sister founded Swiss Smile, Switzerland’s first dental service organization (DSO) and Europe’s first fear-free dental clinic groups, setting new benchmarks for accessible, patient-friendly oral healthcare. In 2007, Drs. Abivardi launched a global brand offering a line of premium oral care products. The same year they received several national and international awards, including the “Businesswoman of the Year Award” and the “Private Dentistry Awards,” among others. Haley also co-ran a dental hygienist school, supporting clinical studies and innovation in dentistry.
Avec plus de deux décennies d'expérience en tant que dentiste, entrepreneure et défenseure de soins dentaires non invasifs et centrés sur le patient, reconnaissant le lien entre la santé bucco-dentaire et la santé globale, Haley est reconnue à l'échelle internationale comme une leader et une innovatrice en matière de santé bucco-dentaire. Sous sa direction, VVardis étend le développement et la commercialisation de Curodont™, son traitement exclusif contre la carie dentaire à un stade précoce qui permet d'intervenir sans percer et préserve la structure naturelle des dents, qui s'appuie sur plus de 25 ans de recherche et plus de 200 études. Haley prend fréquemment la parole lors de forums internationaux sur la santé et les affaires, où elle aborde l'innovation dentaire, l'entrepreneuriat et l'avenir des soins d'intervention précoce.
Haley is based in Zug, Switzerland.
Dre Goly Abivardi, DMD
CEO & Co-Founder
Dr. Goly Abivardi is Chief Executive Officer and Co-Founder of vVARDIS, a Swiss high-growth healthcare company leading innovation in biomimetic and non-invasive technologies for caries management. Since co-founding vVARDIS in 2020 with her sister, Dr. Haley Abivardi, Goly has played a pivotal role in building the company’s global presence and advancing its reputation for scientific excellence. With her forward-thinking leadership she is shaping vVARDIS vision to elevate oral health as a foundation for overall health.
Goly earned her Doctor of Dental Medicine (DMD, Dr. Med. Dent.) from the University of Zurich and completed her dissertation in 2001. She began her career co-leading a public pediatric dental clinic in Switzerland, focused on preventive care for children, particularly from underserved communities. In 2003, she and her sister co-founded Swiss Smile, Switzerland’s first dental service organization (DSO) and Europe’s first fear-free dental clinic groups, introducing a new model of care that emphasized accessibility, comfort, and holistic well-being. In 2007, Drs. Abivardi launched a global brand offering a line of premium oral care products. In 2007, they received several national and international awards including the “Businesswoman of the Year Award” and the “Private Dentistry Awards,” among others. Goly also co-led a dental hygienist school, where they ran clinical studies and research to support advancement in dental technology.
Avec plus de deux décennies d'expérience en tant que dentiste, entrepreneur et défenseur de soins dentaires non invasifs et centrés sur le patient, reconnaissant le lien entre la santé bucco-dentaire et la santé globale, Goly est reconnu à l'échelle internationale comme un leader et un innovateur en matière de santé bucco-dentaire. Sous sa direction, VVardis étend le développement et la commercialisation de Curodont™, son traitement exclusif contre la carie dentaire à un stade précoce qui permet d'intervenir sans percer et préserve la structure naturelle des dents, qui s'appuie sur plus de 25 ans de recherche et plus de 200 études. Goly intervient fréquemment lors de forums internationaux sur la santé et les affaires, où elle aborde l'innovation dentaire, l'entrepreneuriat et l'avenir des soins non invasifs.
Goly is based in Zurich, Switzerland.